ribavirin has been researched along with Extravascular Hemolysis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Balázs, I; Feldbacher, N; Horvath, A; Kollroser, M; Leber, B; Nusshold, C; Posch, A; Rechberger, GN; Sattler, W; Spindelböck, W; Stadlbauer, V; Stauber, RE; Stiegler, P; Streit, A | 1 |
| Bodeau, S; Brochot, E; Domange, B; Duverlie, G; Garçon, L; Handala, L; Helle, F; Nguyen-Khac, E; Ouled-Haddou, H | 1 |
| Cai, QX; Hong, CX; Lin, CS; Zhang, XH; Zhao, ZX | 1 |
| Ahn, SM; Choi, DJ; Jung, YK; Kim, JH; Kim, JS; Kim, YS; Kwon, OS | 1 |
| Karasawa, T; Saito, T; Soga, T; Sugimoto, M; Ueno, Y | 1 |
| Abed, M; Alzoubi, K; Lang, F; Oswald, G | 1 |
| Maliakkal, B; Soota, K | 1 |
| Guo, H; Sun, S; Tang, X; Wang, Y; Yang, Z | 1 |
| Abbati, G; Belussi, F; Bonetto, S; Boninsegna, S; Borghi, A; Carbonieri, A; Corradini, E; Fagiuoli, S; Fattovich, G; Felder, M; Ferrara, F; Ferrari, C; Guido, M; Massari, M; Minola, E; Orlandini, A; Pietrangelo, A; Pozzato, G; Rizzo, G; Rossi, E; Rovere, P; Sardini, C; Tagliazucchi, M; Toniutto, P; Vegetti, A; Ventura, P; Zeneroli, ML | 1 |
| Mallat, ME; Sharara, AI | 1 |
| Black, M; Burke, M; Jain, AB; Singhal, A | 1 |
| Doehring, A; Geisslinger, G; Hofmann, WP; Lötsch, J; Schlecker, C; Ultsch, A; Zeuzem, S | 1 |
| Brochot, E; Capron, D; Castelain, S; Duchaussoy, I; Duverlie, G; François, C; Helle, F; Nguyen-Khac, E; Van Nhien, AN | 1 |
| Bevers, EM; Kleinegris, MC; Koek, GH; Mast, K; Mestrom, EH; Wolfs, JL | 1 |
| Dvorchik, I; Eghtesad, B; Fontes, PA; Fung, JJ; Jain, AB; Kashyap, R; Kingery, L; Shakil, AO; Venkataramanan, R | 1 |
| Cheng, IK; Kuok, UI; Leung, VK; Mao Chan, T; Neng Lai, K; Tang, AW; Tang, S; Wing Ho, Y | 1 |
| Zhaori, G | 1 |
| Bihl, F; Grattagliano, I; Jüni, P; Lauterburg, BH; Palasciano, G; Palmieri, VO; Portincasa, P; Russmann, S | 1 |
| Bajaj, JS; Daniel, J; Franco, J; Ho, S; Knox, JF; McKee, D; Peine, C; Saeian, K; Varma, RR | 1 |
| Grattagliano, I; Lauterburg, BH; Palasciano, G; Palmieri, VO; Portincasa, P; Russmann, S | 1 |
| Blot, C; Mathurin, P; Moussalli, J; Opolon, P; Perrin, M; Plassart, F; Poynard, T; Thevenot, T | 1 |
| Gane, EJ; Lau, JY; Lo, SK; Naoumov, NV; Portmann, BC; Riordan, SM; Williams, R | 1 |
| De Vos, M; Delanghe, JR; Leroux-Roel, G; Van Vlierbergh, H | 1 |
4 review(s) available for ribavirin and Extravascular Hemolysis
| Article | Year |
|---|---|
Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection.
Topics: Anemia, Hemolytic; Animals; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Heme Oxygenase-1; Hemolysis; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Inflammation Mediators; Ribavirin; Treatment Outcome | 2014 |
Strategies for ribavirin prodrugs and delivery systems for reducing the side-effect hemolysis and enhancing their therapeutic effect.
Topics: Animals; Antiviral Agents; Drug Delivery Systems; Hemolysis; Humans; Prodrugs; Ribavirin | 2015 |
Treatment and prevention of hepatitis B and C in thalassemia.
Topics: Antiviral Agents; Hemolysis; Hepatitis B; Hepatitis C; Humans; Ribavirin; Thalassemia; Transfusion Reaction | 2009 |
Antiviral treatment of SARS: can we draw any conclusions?
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hemolysis; Humans; Interferon-alpha; Male; Ribavirin; Severe Acute Respiratory Syndrome; Steroids | 2003 |
4 trial(s) available for ribavirin and Extravascular Hemolysis
| Article | Year |
|---|---|
Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
Topics: Adult; Antiviral Agents; Cell Membrane; Dipyridamole; Erythrocytes; Female; Glutathione; Glutathione Disulfide; Glycogen Storage Disease Type I; Hemolysis; Hepatitis C, Chronic; Humans; In Vitro Techniques; Male; Maleates; Middle Aged; Predictive Value of Tests; Prospective Studies; Ribavirin; Sulfhydryl Compounds | 2004 |
High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin.
Topics: Adult; Antioxidants; Antiviral Agents; Drug Therapy, Combination; Female; Hemolysis; Hepatitis C, Chronic; Humans; Male; Quality of Life; Ribavirin; Vitamin E | 2004 |
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Topics: Adult; Aged; Aspartate Aminotransferases; Female; Hemolysis; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Recurrence; Ribavirin; RNA, Viral | 1998 |
Factors influencing ribavirin-induced hemolysis.
Topics: Adult; Anemia, Hemolytic; Antiviral Agents; Female; Haptoglobins; Hemoglobins; Hemolysis; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Phenotype; Platelet Count; Recombinant Proteins; Ribavirin; Risk Factors | 2001 |
15 other study(ies) available for ribavirin and Extravascular Hemolysis
| Article | Year |
|---|---|
Direct acting antiviral therapy rescues neutrophil dysfunction and reduces hemolysis in hepatitis C infection.
Topics: Aged; Antiviral Agents; Female; Hemolysis; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; Neutrophils; Phagocytosis; Prospective Studies; Ribavirin | 2021 |
DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase.
Topics: Adenosine Triphosphate; Anemia; Antiviral Agents; Dehydroepiandrosterone; Erythrocytes; Glucosephosphate Dehydrogenase; Hemolysis; Hepatitis C, Chronic; Humans; Pentose Phosphate Pathway; Ribavirin | 2017 |
Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Asian People; China; Ethnicity; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Hemolysis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Male; Middle Aged; Pyrophosphatases; Ribavirin; Young Adult | 2013 |
The impact of inosine triphosphatase variants on hemoglobin level and sustained virologic response of chronic hepatitis C in Korean.
Topics: Adult; Alleles; Antiviral Agents; Asian People; Cohort Studies; Drug Therapy, Combination; Female; Genotype; Hemoglobins; Hemolysis; Hepacivirus; Hepatitis C, Chronic; Humans; Inosine Triphosphatase; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Pyrophosphatases; Recombinant Proteins; Republic of Korea; Retrospective Studies; Ribavirin; Treatment Outcome | 2013 |
Metabolome analysis of erythrocytes from patients with chronic hepatitis C reveals the etiology of ribavirin-induced hemolysis.
Topics: Antiviral Agents; Erythrocytes; Glycolysis; Hemolysis; Hepatitis C, Chronic; Humans; Oxidative Stress; Pentose Phosphate Pathway; Ribavirin | 2013 |
Stimulation of suicidal erythrocyte death by ribavirin.
Topics: Calcium; Cell Death; Cell Membrane; Cell Size; Cells, Cultured; Cytosol; Erythrocytes; Hemolysis; Humans; Phosphatidylserines; Ribavirin | 2014 |
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Disease Progression; Female; Ferritins; Hemolysis; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Transferrin; Treatment Outcome | 2009 |
Aggressive use of ribavirin and prolonged course of peginterferon to improve the rate of viral response in liver transplant patients with recurrent hepatitis C viral infection.
Topics: Adult; Antiviral Agents; Blood Transfusion; Drug Administration Schedule; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Genotype; Hematinics; Hemolysis; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Pennsylvania; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2010 |
Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.
Topics: Alleles; Biomarkers, Pharmacological; Drug Resistance, Multiple, Viral; Genetic Association Studies; Genotype; Haplotypes; Hemolysis; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interferons; Interleukins; Membrane Transport Proteins; Polyethylene Glycols; Pyrophosphatases; Recombinant Proteins; Ribavirin | 2011 |
A new tool to study ribavirin-induced haemolysis.
Topics: Adenosine Triphosphate; Adult; Anemia, Hemolytic; Dipyridamole; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythrocytes; Glutathione; Hematologic Tests; Hemolysis; Hepacivirus; Hepatitis C, Chronic; Humans; Inhibitory Concentration 50; Interferon alpha-2; Interferon-alpha; Poliovirus; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin; RNA, Viral | 2012 |
Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activity.
Topics: Adenosine Triphosphate; Antiviral Agents; Cells, Cultured; Erythrocytes; Hemolysis; Humans; Ionomycin; Phosphatidylserines; Phospholipid Transfer Proteins; Ribavirin | 2012 |
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Hemolysis; Hepatitis C; Humans; Interferon-alpha; Kidney; Liver; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Ribavirin | 2002 |
Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hemolysis; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Transplantation; Liver; Male; Middle Aged; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome | 2003 |
Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.
Topics: Adult; Anemia; Antiviral Agents; Disulfides; Erythrocyte Membrane; Erythrocytes; Female; Glutathione Peroxidase; Hemolysis; Hepatitis C; Humans; In Vitro Techniques; Male; Membrane Proteins; Middle Aged; Oxidative Stress; Predictive Value of Tests; Ribavirin; Sulfhydryl Compounds; Thioredoxins | 2005 |
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin.
Topics: Adult; Aged; Anemia; Antiviral Agents; Azathioprine; Chronic Disease; Contraindications; Drug Therapy, Combination; Female; Hemoglobins; Hemolysis; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Retrospective Studies; Ribavirin | 1997 |